MedTrace Logo

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

NCT04427384 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-02-13

No results posted yet for this study

Summary

The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

Conditions

  • Brain Tumor, Recurrent
  • Brain Tumor
  • Brain Tumor, Primary
  • Brain Tumor - Metastatic
  • Brain Tumor, Adult: Glioblastoma
  • Brain Tumor, Adult Meningioma

Interventions

DEVICE

GammaTile

Surgically Targeted Radiation Therapy

Sponsors & Collaborators

  • GT Medical Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael A. Garcia, MD, MS · GT Medical Technologies

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-11
Primary Completion
2028-10-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04427384 on ClinicalTrials.gov